Cia Energetica de Minas Gerais CEMIG-ADR (CIG) Reaches $2.42 After 7.00% Up Move; Pluristem Therapeutics (PSTI) Sentiment Is 0.5

June 28, 2017 - By Nellie Frank

Pluristem Therapeutics Inc. is a developer of placenta cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The company has market cap of $121.56 million. The Company’s lead indications are critical limb ischemia , recovery after surgery for femoral neck fracture and acute radiation syndrome. It currently has negative earnings. The Company’s activities are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies.

The stock of Cia Energetica de Minas Gerais CEMIG-ADR (NYSE:CIG) is a huge mover today! About 434,900 shares traded. Cia Energetica de Minas Gerais CEMIG-ADR (NYSE:CIG) has risen 59.02% since June 28, 2016 and is uptrending. It has outperformed by 42.32% the S&P500.The move comes after 5 months positive chart setup for the $3.13B company. It was reported on Jun, 28 by Barchart.com. We have $2.59 PT which if reached, will make NYSE:CIG worth $219.10 million more.

Companhia Energetica de Minas Gerais-CEMIG is a holding firm that is engaged in the generation, transmission and distribution of electricity. The company has market cap of $3.13 billion. The Company’s divisions include Generation, Transmission, Distribution, Telecom, Gas and Other. It has a 15.05 P/E ratio. The Company, through its interests in subsidiaries or jointly controlled entities, is engaged in the activities of the construction and operation of systems for sale of electricity, as well as various fields of energy and telecommunications, for the purpose of commercial operation.

Oppenheimer & Co Inc holds 0.01% of its portfolio in Pluristem Therapeutics Inc. for 127,000 shares. Bank Of America Corp De owns 125 shares or 0% of their US portfolio. Moreover, California Public Employees Retirement System has 0% invested in the company for 181,700 shares. The Illinois-based Citadel Advisors Llc has invested 0% in the stock. Citigroup Inc, a New York-based fund reported 1,040 shares.

About 140,750 shares traded or 4.51% up from the average. Pluristem Therapeutics Inc. (PSTI) has declined 7.80% since June 28, 2016 and is downtrending. It has underperformed by 24.50% the S&P500.